Consolidated Statements of Shareholders' Equity - USD ($) $ in Thousands	Common Stock [Member] Previously Reported [Member]	Common Stock [Member] Revision of Prior Period, Adjustment [Member]	Common Stock [Member]	Additional Paid-in Capital [Member] Previously Reported [Member]	Additional Paid-in Capital [Member] Revision of Prior Period, Adjustment [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member] Previously Reported [Member]	Retained Earnings [Member]	AOCI Attributable to Parent [Member] Previously Reported [Member]	AOCI Attributable to Parent [Member]	Previously Reported [Member]	Total
Beginning balance at Dec. 31, 2020	$ 1	$ 5	$ 6	$ 835	$ (5)	$ 830	$ (63,038)	$ (63,038)	$ 133	$ 133	$ (62,069)	$ (62,069)
Beginning balance (in shares) at Dec. 31, 2020	10,245,074	50,536,901	60,781,975
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation						72						72
Foreign currency translation adjustments										(14)		(14)
Net income (loss)								(3,595)				(3,595)
Ending balance at Mar. 31, 2021			$ 6			902		(66,633)		119		(65,606)
Ending balance (in shares) at Mar. 31, 2021			60,781,975
Beginning balance at Dec. 31, 2020	$ 1	$ 5	$ 6	835	(5)	830	(63,038)	(63,038)	133	133	(62,069)	(62,069)
Beginning balance (in shares) at Dec. 31, 2020	10,245,074	50,536,901	60,781,975
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Foreign currency translation adjustments												48
Net income (loss)												(21,006)
Ending balance at Sep. 30, 2021			$ 6			3,980		(84,044)		181		(79,877)
Ending balance (in shares) at Sep. 30, 2021			60,903,829
Beginning balance at Mar. 31, 2021			$ 6			902		(66,633)		119		(65,606)
Beginning balance (in shares) at Mar. 31, 2021			60,781,975
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation						271						271
Foreign currency translation adjustments										85		85
Net income (loss)								(6,786)				(6,786)
Ending balance at Jun. 30, 2021			$ 6			1,173		(73,419)		204		(72,036)
Ending balance (in shares) at Jun. 30, 2021			60,781,975
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation						2,787						2,787
Foreign currency translation adjustments										(23)		(23)
Issuance of common stock upon exercise of stock options						20						20
Issuance of common stock upon exercise of stock options (in shares)			121,854
Net income (loss)								(10,625)				(10,625)
Ending balance at Sep. 30, 2021			$ 6			3,980		(84,044)		181		(79,877)
Ending balance (in shares) at Sep. 30, 2021			60,903,829
Beginning balance at Dec. 31, 2021		$ 6	$ 6	5,604	(6)	5,598	(94,293)	(94,293)	367	367	(88,322)	(88,322)
Beginning balance (in shares) at Dec. 31, 2021	10,474,509	51,668,426	62,142,935
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Conversion of redeemable convertible preferred stock to common stock in connection with reverse recapitalization upon Business Combination			$ 21			269,920						269,941
Conversion of redeemable convertible preferred stock to common stock in connection with reverse recapitalization upon Business Combination (in shares)			213,960,286
Business Combination and PIPE Financing, net of redemptions and transaction costs			$ 7			234,514						234,521
Business Combination and PIPE Financing, net of redemptions and transaction costs (in shares)			71,767,824
Forfeitures of Earn-Out restricted shares			(9,080)
Stock-based compensation						3,186						3,186
Foreign currency translation adjustments										109		109
Issuance of common stock upon exercise of stock options						4						4
Issuance of common stock upon exercise of stock options (in shares)			31,217
Net income (loss)								(27,033)				(27,033)
Ending balance at Mar. 31, 2022			$ 34			513,222		(121,326)		476		392,406
Ending balance (in shares) at Mar. 31, 2022			347,893,182
Beginning balance at Dec. 31, 2021		$ 6	$ 6	$ 5,604	$ (6)	5,598	$ (94,293)	(94,293)	$ 367	367	$ (88,322)	(88,322)
Beginning balance (in shares) at Dec. 31, 2021	10,474,509	51,668,426	62,142,935
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Foreign currency translation adjustments												(2,462)
Net income (loss)												(42,346)
Ending balance at Sep. 30, 2022			$ 34			532,413		(136,639)		(2,095)		$ 393,713
Ending balance (in shares) at Sep. 30, 2022			349,772,538									349,772,538
Beginning balance at Mar. 31, 2022			$ 34			513,222		(121,326)		476		$ 392,406
Beginning balance (in shares) at Mar. 31, 2022			347,893,182
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Release of accrued transaction costs related to Business Combination and PIPE Financing						6,174						6,174
Stock-based compensation						5,547						5,547
Foreign currency translation adjustments										(1,377)		(1,377)
Issuance of common stock upon exercise of stock options						38						38
Issuance of common stock upon exercise of stock options (in shares)			337,453
Net income (loss)								9,015				9,015
Ending balance at Jun. 30, 2022			$ 34			524,981		(112,311)		(901)		411,803
Ending balance (in shares) at Jun. 30, 2022			348,230,635
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation						7,214						7,214
Foreign currency translation adjustments										(1,194)		(1,194)
Issuance of common stock upon exercise of stock options						218						218
Issuance of common stock upon exercise of stock options (in shares)			1,376,206
Restricted stock units vested			165,697
Net income (loss)								(24,328)				(24,328)
Ending balance at Sep. 30, 2022			$ 34			$ 532,413		$ (136,639)		$ (2,095)		$ 393,713
Ending balance (in shares) at Sep. 30, 2022			349,772,538									349,772,538